Peripartum cardiomyopathy

Hemant K. Satpathy, Donald Frey, Ruby Satpathy, Chabi Satpathy, Alfred Fleming, Syed M. Mohiuddin, Jimmy Khandalavala

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Peripartum cardiomyopathy (PPCM) is a rare, idiopathic, life-threatening disease of late pregnancy and early puerperium, occurring in patients with previously healthy hearts. Risk factors include multiparity, age > 30 years, African American race, multiple pregnancies, obesity, hypertension, and toxemia. Signs and symptoms of PPCM resemble systolic heart failure, and it is diagnosed by exclusion. An echocardiogram typically reveals an ejection fraction of <45% and/or fractional shortening of <30%, along with a left ventricular end-diastolic dimension > 2.7 cm/m2 of body surface area. Early diagnosis and treatment are important for a successful outcome. Management is similar to other forms of systolic heart failure. Patients with PPCM are at high risk of thromboembolism, and therefore anticoagulation therapy should be considered. The prognosis is variable, ranging from complete recovery, to worsening heart failure requiring cardiac transplantation, or death. Future pregnancies are often discouraged because of the high mortality rate and risk of recurrence.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalPostgraduate Medicine
Volume120
Issue number1
DOIs
StatePublished - Apr 2008

Fingerprint

Peripartum Period
Cardiomyopathies
Systolic Heart Failure
Toxemia
Pregnancy
Multiple Pregnancy
Body Surface Area
Thromboembolism
Heart Transplantation
Parity
African Americans
Postpartum Period
Signs and Symptoms
Early Diagnosis
Heart Failure
Obesity
Hypertension
Recurrence
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Satpathy, H. K., Frey, D., Satpathy, R., Satpathy, C., Fleming, A., Mohiuddin, S. M., & Khandalavala, J. (2008). Peripartum cardiomyopathy. Postgraduate Medicine, 120(1), 28-32. https://doi.org/10.3810/pgm.2008.04.1757

Peripartum cardiomyopathy. / Satpathy, Hemant K.; Frey, Donald; Satpathy, Ruby; Satpathy, Chabi; Fleming, Alfred; Mohiuddin, Syed M.; Khandalavala, Jimmy.

In: Postgraduate Medicine, Vol. 120, No. 1, 04.2008, p. 28-32.

Research output: Contribution to journalArticle

Satpathy, HK, Frey, D, Satpathy, R, Satpathy, C, Fleming, A, Mohiuddin, SM & Khandalavala, J 2008, 'Peripartum cardiomyopathy', Postgraduate Medicine, vol. 120, no. 1, pp. 28-32. https://doi.org/10.3810/pgm.2008.04.1757
Satpathy HK, Frey D, Satpathy R, Satpathy C, Fleming A, Mohiuddin SM et al. Peripartum cardiomyopathy. Postgraduate Medicine. 2008 Apr;120(1):28-32. https://doi.org/10.3810/pgm.2008.04.1757
Satpathy, Hemant K. ; Frey, Donald ; Satpathy, Ruby ; Satpathy, Chabi ; Fleming, Alfred ; Mohiuddin, Syed M. ; Khandalavala, Jimmy. / Peripartum cardiomyopathy. In: Postgraduate Medicine. 2008 ; Vol. 120, No. 1. pp. 28-32.
@article{9a317852e8504e3981b514fd6016f946,
title = "Peripartum cardiomyopathy",
abstract = "Peripartum cardiomyopathy (PPCM) is a rare, idiopathic, life-threatening disease of late pregnancy and early puerperium, occurring in patients with previously healthy hearts. Risk factors include multiparity, age > 30 years, African American race, multiple pregnancies, obesity, hypertension, and toxemia. Signs and symptoms of PPCM resemble systolic heart failure, and it is diagnosed by exclusion. An echocardiogram typically reveals an ejection fraction of <45{\%} and/or fractional shortening of <30{\%}, along with a left ventricular end-diastolic dimension > 2.7 cm/m2 of body surface area. Early diagnosis and treatment are important for a successful outcome. Management is similar to other forms of systolic heart failure. Patients with PPCM are at high risk of thromboembolism, and therefore anticoagulation therapy should be considered. The prognosis is variable, ranging from complete recovery, to worsening heart failure requiring cardiac transplantation, or death. Future pregnancies are often discouraged because of the high mortality rate and risk of recurrence.",
author = "Satpathy, {Hemant K.} and Donald Frey and Ruby Satpathy and Chabi Satpathy and Alfred Fleming and Mohiuddin, {Syed M.} and Jimmy Khandalavala",
year = "2008",
month = "4",
doi = "10.3810/pgm.2008.04.1757",
language = "English",
volume = "120",
pages = "28--32",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "1",

}

TY - JOUR

T1 - Peripartum cardiomyopathy

AU - Satpathy, Hemant K.

AU - Frey, Donald

AU - Satpathy, Ruby

AU - Satpathy, Chabi

AU - Fleming, Alfred

AU - Mohiuddin, Syed M.

AU - Khandalavala, Jimmy

PY - 2008/4

Y1 - 2008/4

N2 - Peripartum cardiomyopathy (PPCM) is a rare, idiopathic, life-threatening disease of late pregnancy and early puerperium, occurring in patients with previously healthy hearts. Risk factors include multiparity, age > 30 years, African American race, multiple pregnancies, obesity, hypertension, and toxemia. Signs and symptoms of PPCM resemble systolic heart failure, and it is diagnosed by exclusion. An echocardiogram typically reveals an ejection fraction of <45% and/or fractional shortening of <30%, along with a left ventricular end-diastolic dimension > 2.7 cm/m2 of body surface area. Early diagnosis and treatment are important for a successful outcome. Management is similar to other forms of systolic heart failure. Patients with PPCM are at high risk of thromboembolism, and therefore anticoagulation therapy should be considered. The prognosis is variable, ranging from complete recovery, to worsening heart failure requiring cardiac transplantation, or death. Future pregnancies are often discouraged because of the high mortality rate and risk of recurrence.

AB - Peripartum cardiomyopathy (PPCM) is a rare, idiopathic, life-threatening disease of late pregnancy and early puerperium, occurring in patients with previously healthy hearts. Risk factors include multiparity, age > 30 years, African American race, multiple pregnancies, obesity, hypertension, and toxemia. Signs and symptoms of PPCM resemble systolic heart failure, and it is diagnosed by exclusion. An echocardiogram typically reveals an ejection fraction of <45% and/or fractional shortening of <30%, along with a left ventricular end-diastolic dimension > 2.7 cm/m2 of body surface area. Early diagnosis and treatment are important for a successful outcome. Management is similar to other forms of systolic heart failure. Patients with PPCM are at high risk of thromboembolism, and therefore anticoagulation therapy should be considered. The prognosis is variable, ranging from complete recovery, to worsening heart failure requiring cardiac transplantation, or death. Future pregnancies are often discouraged because of the high mortality rate and risk of recurrence.

UR - http://www.scopus.com/inward/record.url?scp=45549101456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549101456&partnerID=8YFLogxK

U2 - 10.3810/pgm.2008.04.1757

DO - 10.3810/pgm.2008.04.1757

M3 - Article

VL - 120

SP - 28

EP - 32

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 1

ER -